The Impact of an Evidence-based Myth-busting Information Intervention on Maternal Food Allergy Related Quality of Life, Anxiety and Self-efficacy
Launched by CHILDREN'S HEALTH IRELAND · Jan 23, 2024
Trial Information
Current as of July 06, 2025
Completed
Keywords
ClinConnect Summary
Carers of food allergic children report that their information needs are greatest at the beginning of their journey when their child first experiences a food allergic reaction. Unfortunately, wait times to attend specialist paediatric allergy clinics can be lengthy. Thus, families can experience a prolonged time-gap between the initial allergic reaction and accessing diagnostic testing and benefitting from multi-disciplinary support and education. Furthermore, carers report often contradictory advice from non-specialist Healthcare Professionals (HCPs). This in turn encourages carers to look...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • First referral to Children's Health Ireland allergy service for evaluation of 'Immediate type' IgE food allergy.
- • Referral accepted and triaged to a waiting list between 30 months to six months prior to study commencement.
- • Child aged between three years and 12 years at the time of study commencement.
- Exclusion Criteria:
- • Referral source from Children's Health Ireland (CHI) dermatology or immunology services or the patient already attends services that will evaluate food allergy such as CHI dermatology and /or immunology.
- • Child younger than three years and older than 12 years at the time of study commencement.
- • Referral information is not suggestive of an IgE mediated food allergy.
- • Complex referral history suggestive of chronic urticaria, mast cell disorders or eosinophilic oesophagitis.
About Children's Health Ireland
Children's Health Ireland (CHI) is a leading pediatric healthcare organization dedicated to improving the health and well-being of children and young people across Ireland. As a prominent clinical trial sponsor, CHI is committed to advancing pediatric medicine through innovative research and the rigorous evaluation of new therapies and interventions. By fostering collaboration among healthcare professionals, researchers, and families, CHI aims to enhance treatment options and outcomes for children, ensuring that their unique healthcare needs are met with the highest standards of care and ethical oversight.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dublin, , Ireland
Patients applied
Trial Officials
Aideen Byrne, PhD
Principal Investigator
Children's Health Ireland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported